About the journal
Future Oncology is a journal published by Future Medicine in United Kingdom. It is listed in MEDLINE and PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Future Medicine
- ISSN
- 1479-6694 · 1744-8301
- Country
- United Kingdom
- Access
- Not open access / not declared
- Official website
- http://www.futuremedicine.com/loi/fon
Index listings
- MEDLINE · 2005-01-01
- PUBMED · 2019-02-28
- Indexing
- MEDLINE · PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Active — latest works 2026
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
5603
Last recorded publication year
2026
h-index
111
i10-index
2456
From OpenAlex open data (CC0).
Editorial & policy5
- Observed digital preservation (Keepers registry)— snapshot 2026-09-21
- CLOCKSSPortico
- Norwegian register (HK-dir)— 2026
- Level 1 — approved scholarly channel
- Open references deposited at Crossref
- 80%
- ORCID iDs in current deposits
- 56%
- Enrolled in Crossref Similarity Check
- ✓
- Deposits licence metadata at Crossref
- ✓
Identity & continuity2
- Source type
- journal
- NLM unique ID (PubMed)
- 101256629
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Cancer Immunotherapy and Biomarkers
- Cancer Immunotherapy and Biomarkers
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Lung Cancer Research Studies
- Lung Cancer Research Studies
Show all subjects (50)
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Prostate Cancer Treatment and Research
- Prostate Cancer Treatment and Research
- Gastric Cancer Management and Outcomes
- Gastric Cancer Management and Outcomes
- Lung Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatocellular Carcinoma Treatment and Prognosis
- Breast Cancer Treatment Studies
- Breast Cancer Treatment Studies
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Pancreatic and Hepatic Oncology Research
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- CAR-T cell therapy research
- Renal cell carcinoma treatment
- Renal cell carcinoma treatment
- Prostate Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Advanced Breast Cancer Therapies
- Chronic Lymphocytic Leukemia Research
- Chronic Lymphocytic Leukemia Research
- Advanced Breast Cancer Therapies
- Multiple Myeloma Research and Treatments
- Multiple Myeloma Research and Treatments
- Ovarian cancer diagnosis and treatment
- Ovarian cancer diagnosis and treatment
- Sarcoma Diagnosis and Treatment
- Sarcoma Diagnosis and Treatment
- Bladder and Urothelial Cancer Treatments
- Bladder and Urothelial Cancer Treatments
- Immunotherapy and Immune Responses
- Immunotherapy and Immune Responses
- Cancer Cells and Metastasis
- Cancer Cells and Metastasis
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ